CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,120 enrolled
Drug / intervention
Implantable defibrillator +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00661037
NCT00661037N/ACompleted
CompareCT.gov

SAFEty of Two Strategies of ICD Management at Implantation

Boston Scientific Corporation·observational·Posted Apr 18, 2008·Updated Jul 21, 2017

In Brief

An observational study evaluating Implantable defibrillator for Ventricular Fibrillation and 2 related conditions. Completed, enrolled 2,120 participants across 1 site.

Detailed Summary

The aim of this prospective observational study is to evaluate the safety, over a follow-up of 2 years, of two strategies, consisting in performing or not performing defibrillation testing(DT) during first implant of implantable cardioverter defibrillator

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVentricular Fibrillation, Ventricular Flutter, Sudden Cardiac Death
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 18, 2008
Enrollment StartMar 1, 2008
Primary CompletionMay 1, 2011
Study CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 18.2 years ago

Interventions

Implantable defibrillatordevice

Implantable defibrillator to reduce ventricular arrhythmias via shock.

Implantable defibrillatordevice

Implantable defibrillator to reduce ventricular arrhythmias via shock.